Alivus Life Sciences Ltd (ALIVUS)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 953.00
% Change: 3.25% (Prev Close: 923.00)

Volume: 77,686
% Change: 51.55% (Prev Volume: 51,260)

Delivery: 36,998
Delivery % : 47.63
% Change: 16.87% (Prev Delivery: 31,658)

Turnover: 732 Lacs
% Change: 54.80% (Prev Turnover: 473)

πŸ’Ή EOD Valuation

P/E Ratio: 23.56
P/B Ratio: 4.14
Market Cap: 11693 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: ALIVUS
Market Cap: 11591 Rs. Cr.
Face Value: 2.00 Rs.

52 Week High: 1335.10
52 Week Low: 827.10

All-Time High: 1335.10 Rs.
All-Time Low: 369.00 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-5.00% | -6.83% | -13.12% | -12.82% | 28.92%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 74.94%

Change (3Y | 1Y): -7.91% | -0.05%

Pledged %: 0.00%

FII Holding

FII Holding: 6.42%

Change (3Y | 1Y): -1.16% | -0.15%

DII Holding

DII Holding: 5.62%

Change (3Y | 1Y): 4.83% | 0.43%

Public Holding: 13.03%

🏦 Financial Strength

Debt to Equity: 0.02
Debt: 56.61 Rs. Cr.

Book Value: 229.92 Rs.
Current Ratio: 3.95
Interest Coverage: 202.48
Free Cash Flow: 225.96 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 4.65%

Sales Growth Qtr (YOY | QoQ):
2.25% | -7.34%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
9.20% | 3.98% | 4.65%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 10.91%

Profit Growth Qtr (YOY | QoQ):
9.02% | -14.33%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
8.92% | 4.71% | 10.91%

EPS Rs.

EPS (TTM): 40.45 Rs.

EPS Qtr (Last Year | Latest):
9.10 Rs. | 9.91 Rs.

EPS Annual (Last Annual | Annual March):
38.43 Rs. | 39.63 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
-52.37% | 4.71%

Net Profit Rs. Cr.

Net Profit (TTM): 495.69 Rs. Cr.

Net Profit (Annual - March): 485.63 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
111.48| 141.87 | 121.54

EBITDA Rs. Cr.

EBITDA (Quarter): 181.30 Rs. Cr.
EBITDA (Previous Yr Ql): 164.98 Rs. Cr.

EBITDA (Annual - March): 711.36 Rs. Cr.
EBITDA (Previous Annual): 686.99 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
7.95% | 4.05%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 28.97%

OPM Qtr (Previous | Current):
30.55% | 28.63%

OPM Annual (5 Yrs | Last Yr | March):
29.62% | 29.56% | 28.67%

Return on Equity %

ROE: 18.69%

ROE (5 Yrs | 3 Yrs | Last Yr):
24.66% | 20.56% | 21.09%

Return on Capital Employed %

ROCE: 24.92%

ROCE (5 Yrs | 3 Yrs | Last Yr):
44.40% | 27.64% | 28.11%

Return on Assets %

ROA (TTM): 15.37%

ROA (5 Yrs | 3 Yrs | Last Yr):
17.62% | 16.81% | 16.98%

PEG Ratio: 4.96
Dividend Yield: 0.53%

PE 3 Yrs: 19.12
PE 5 Yrs: 15.35

Dividend Yield: 0.53%

πŸ‘₯ Company

Alivus Life Sciences Ltd

ALIVUS

Promoter Holding: %